proliferative vitreoretinopathy
Conditions
Interventions
October 2011~December 2020 tamponade agent of vitrectomy for proliferative vitreoretinopathy
Sponsors
Department of Ophthalmology, Graduate School of Medical and Dental Science, Kagoshima University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: proliferative vitreoretinopathy
Exclusion criteria
Exclusion criteria: proliferative vitreoretinopathy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| visual acuity | — |
Secondary
| Measure | Time frame |
|---|---|
| postoperative complications | — |
Countries
Japan
Contacts
Public ContactToshifumi Yamashita
Graduate School of Medical and Dental Science, Kagoshima University Department of Ophthalmology
Outcome results
None listed